High fish and vegetable intake and low amounts of sugary beverages, starting at one year old, had a significant impact on IBD risk in over 80,000 people.
While the study didn't include calcium supplementation, it was nonetheless "striking" that vitamin D alone made no difference, according to the authors.
The European Commission approved of 3-fucosyllactose as a novel food ingredient, marking a milestone for improving market access of a broader range of HMOs.
Shortly after the approval of the HMOs 2’-FL and LNnT, global suppliers dsm-firmenich and IFF were among the first companies to receive individual clearance.